在重症监护室的基于科学的流体治疗:Rinaldo Bellomo教授的遗产
Simon R Finfer1,2, Naomi E Hammond1,3, John A Myburgh1,4
1The George Institute for Global Health, University of New South Wales, Sydney, Australia.
概括
盐水与白液体评估试验是重症监护中的一个里程碑式的研究,显著地推进了液体复苏研究. 这项务实的试验为重症监护流体管理制定了新的全球标准.
科学领域:
- 关键护理医学 关键护理医学
- 临床试验 研究 研究 临床试验 临床试验
- 液体复苏 复苏 复苏 液体复苏
背景情况:
- 澳大利亚和新西兰重症监护协会临床试验小组 (CTG) 源自对复苏和维护液体的研究.
- 教授Rinaldo Bellomo在开发有影响力的重症监护试验方面发挥了关键作用.
研究的目的:
- 为了强调Rinaldo Bellomo教授对关键大型临床试验的贡献.
- 详细说明这些试验对全球重症监护研究和实践的影响.
主要方法:
- 盐水与白液体评估 (SAFE) 研究是全球第一个在重症监护病房进行的大规模实用性试验.
- 贝洛莫教授获得了多个来源的资金,并为SAFE研究提供了流体供应和遮.
- 这项SAFE研究作为后续试验的模板,例如Crystalloid对Hydroxyethyl粉研究.
主要成果:
- 这项SAFE研究是CTG在"新英格兰医学杂志"上首次发表的.
- 试验的成功在国际上确立了CTG,并影响了流体管理实践.
- 这项研究证明了在重症监护中进行大规模的盲目的液体试验的可行性.
结论:
- 贝洛莫教授的领导和创新方法对重大重症监护试验的成功至关重要.
- 该SAFE研究和随后的试验从根本上改变了重症监护室液体复苏的格局.
- 在全球重症监护研究中CTG的影响力很大程度上是由这些基础研究塑造的.
更多相关视频
07:59Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
Published on: July 28, 2018
10.9K
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
2.5K
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
826
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
826
Acute Respiratory Failure-V
775
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
775
Heart Failure VI: Adjunct Therapies
635
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
635
Acute Kidney Injury V: Interprofessional Care
548
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
548
